Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1989 May 15;140(10):1149–1154.

Anorexia nervosa and bulimia nervosa.

D S Goldbloom 1, S H Kennedy 1, A S Kaplan 1, D B Woodside 1
PMCID: PMC1269054  PMID: 2565759

Abstract

No definitive therapy exists for anorexia nervosa (AN) or bulimia nervosa (BN). Nevertheless, biologic and psychologic research into these disorders has increased over the last decade. We examine the various drugs available for treatment. Advances in pharmacotherapy for AN have been modest and have reflected efforts either to stimulate hunger and weight gain or to control complications of the starvation process. Food remains the "drug" of choice. Antidepressants have been found to be beneficial in the treatment of BN. The meaning of this in the context of a relation between BN and mood disorders remains unclear, since coexistent depression does not predict a positive response to these drugs. Pharmacotherapy represents a single but important dimension of the management of patients with eating disorders. The optimal integration of drug therapy and psychotherapy and the identification of predictors of a positive response to drugs have yet to be addressed by clinical research.

Full text

PDF
1149

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barlow J., Blouin J., Blouin A., Perez E. Treatment of bulimia with desipramine: a double-blind crossover study. Can J Psychiatry. 1988 Mar;33(2):129–133. doi: 10.1177/070674378803300211. [DOI] [PubMed] [Google Scholar]
  2. Biederman J., Herzog D. B., Rivinus T. M., Harper G. P., Ferber R. A., Rosenbaum J. F., Harmatz J. S., Tondorf R., Orsulak P. J., Schildkraut J. J. Amitriptyline in the treatment of anorexia nervosa: a double-blind, placebo-controlled study. J Clin Psychopharmacol. 1985 Feb;5(1):10–16. [PubMed] [Google Scholar]
  3. Blouin A. G., Blouin J. H., Perez E. L., Bushnik T., Zuro C., Mulder E. Treatment of bulimia with fenfluramine and desipramine. J Clin Psychopharmacol. 1988 Aug;8(4):261–269. [PubMed] [Google Scholar]
  4. Casper R. C., Schlemmer R. F., Jr, Javaid J. I. A placebo-controlled crossover study of oral clonidine in acute anorexia nervosa. Psychiatry Res. 1987 Mar;20(3):249–260. doi: 10.1016/0165-1781(87)90085-0. [DOI] [PubMed] [Google Scholar]
  5. Condon J. T. Long-term neuroleptic therapy in chronic anorexia nervosa complicated by tardive dyskinesia. A case report. Acta Psychiatr Scand. 1986 Feb;73(2):203–206. doi: 10.1111/j.1600-0447.1986.tb10588.x. [DOI] [PubMed] [Google Scholar]
  6. Crisp A. H., Lacey J. H., Crutchfield M. Clomipramine and 'drive' in people with anorexia nervosa: an in-patient study. Br J Psychiatry. 1987 Mar;150:355–358. doi: 10.1192/bjp.150.3.355. [DOI] [PubMed] [Google Scholar]
  7. DALLY P. J., SARGANT W. A new treatment of anorexia nervosa. Br Med J. 1960 Jun 11;1(5188):1770–1773. doi: 10.1136/bmj.1.5188.1770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Domstad P. A., Shih W. J., Humphries L., DeLand F. H., Digenis G. A. Radionuclide gastric emptying studies in patients with anorexia nervosa. J Nucl Med. 1987 May;28(5):816–819. [PubMed] [Google Scholar]
  9. Drewnowski A., Yee D. K., Krahn D. D. Bulimia in college women: incidence and recovery rates. Am J Psychiatry. 1988 Jun;145(6):753–755. doi: 10.1176/ajp.145.6.753. [DOI] [PubMed] [Google Scholar]
  10. Dubois A., Gross H. A., Richter J. E., Ebert M. H. Effect of bethanechol on gastric functions in primary anorexia nervosa. Dig Dis Sci. 1981 Jul;26(7):598–600. doi: 10.1007/BF01367671. [DOI] [PubMed] [Google Scholar]
  11. Fairburn C. G., Kirk J., O'Connor M., Cooper P. J. A comparison of two psychological treatments for bulimia nervosa. Behav Res Ther. 1986;24(6):629–643. doi: 10.1016/0005-7967(86)90058-6. [DOI] [PubMed] [Google Scholar]
  12. Green R. S., Rau J. H. Treatment of compulsive eating disturbances with anticonvulsant medication. Am J Psychiatry. 1974 Apr;131(4):428–432. [PubMed] [Google Scholar]
  13. Grimes J. D., Hassan M. N., Preston D. N. Adverse neurologic effects of metoclopramide. Can Med Assoc J. 1982 Jan 1;126(1):23–25. [PMC free article] [PubMed] [Google Scholar]
  14. Gross H., Ebert M. H., Faden V. B., Goldberg S. C., Kaye W. H., Caine E. D., Hawks R., Zinberg N. A double-blind trial of delta 9-tetrahydrocannabinol in primary anorexia nervosa. J Clin Psychopharmacol. 1983 Jun;3(3):165–171. [PubMed] [Google Scholar]
  15. Herzog D. B., Keller M. B., Lavori P. W. Outcome in anorexia nervosa and bulimia nervosa. A review of the literature. J Nerv Ment Dis. 1988 Mar;176(3):131–143. doi: 10.1097/00005053-198803000-00001. [DOI] [PubMed] [Google Scholar]
  16. Hsu L. K. Treatment of bulimia with lithium. Am J Psychiatry. 1984 Oct;141(10):1260–1262. doi: 10.1176/ajp.141.10.1260. [DOI] [PubMed] [Google Scholar]
  17. Hudson J. I., Pope H. G., Jr, Yurgelun-Todd D., Jonas J. M., Frankenburg F. R. A controlled study of lifetime prevalence of affective and other psychiatric disorders in bulimic outpatients. Am J Psychiatry. 1987 Oct;144(10):1283–1287. doi: 10.1176/ajp.144.10.1283. [DOI] [PubMed] [Google Scholar]
  18. Hughes P. L., Wells L. A., Cunningham C. J., Ilstrup D. M. Treating bulimia with desipramine. A double-blind, placebo-controlled study. Arch Gen Psychiatry. 1986 Feb;43(2):182–186. doi: 10.1001/archpsyc.1986.01800020092012. [DOI] [PubMed] [Google Scholar]
  19. Jonas J. M., Gold M. S. The use of opiate antagonists in treating bulimia: a study of low-dose versus high-dose naltrexone. Psychiatry Res. 1988 May;24(2):195–199. doi: 10.1016/0165-1781(88)90062-5. [DOI] [PubMed] [Google Scholar]
  20. Kaplan A. S., Garfinkel P. E., Darby P. L., Garner D. M. Carbamazepine in the treatment of bulimia. Am J Psychiatry. 1983 Sep;140(9):1225–1226. doi: 10.1176/ajp.140.9.1225. [DOI] [PubMed] [Google Scholar]
  21. Katz R. L., Keen C. L., Litt I. F., Hurley L. S., Kellams-Harrison K. M., Glader L. J. Zinc deficiency in anorexia nervosa. J Adolesc Health Care. 1987 Sep;8(5):400–406. doi: 10.1016/0197-0070(87)90227-0. [DOI] [PubMed] [Google Scholar]
  22. Kennedy S. H., Piran N., Warsh J. J., Prendergast P., Mainprize E., Whynot C., Garfinkel P. E. A trial of isocarboxazid in the treatment of bulimia nervosa. J Clin Psychopharmacol. 1988 Dec;8(6):391–396. [PubMed] [Google Scholar]
  23. McCallum R. W., Grill B. B., Lange R., Planky M., Glass E. E., Greenfeld D. G. Definition of a gastric emptying abnormality in patients with anorexia nervosa. Dig Dis Sci. 1985 Aug;30(8):713–722. doi: 10.1007/BF01320484. [DOI] [PubMed] [Google Scholar]
  24. Mitchell J. E., Groat R. A placebo-controlled, double-blind trial of amitriptyline in bulimia. J Clin Psychopharmacol. 1984 Aug;4(4):186–193. [PubMed] [Google Scholar]
  25. Mitchell J. E., Laine D. E., Morley J. E., Levine A. S. Naloxone but not CCK-8 may attenuate binge-eating behavior in patients with the bulimia syndrome. Biol Psychiatry. 1986 Dec;21(14):1399–1406. doi: 10.1016/0006-3223(86)90331-8. [DOI] [PubMed] [Google Scholar]
  26. Pope H. G., Jr, Hudson J. I., Jonas J. M., Yurgelun-Todd D. Bulimia treated with imipramine: a placebo-controlled, double-blind study. Am J Psychiatry. 1983 May;140(5):554–558. doi: 10.1176/ajp.140.5.554. [DOI] [PubMed] [Google Scholar]
  27. Rigaud D., Bedig G., Merrouche M., Vulpillat M., Bonfils S., Apfelbaum M. Delayed gastric emptying in anorexia nervosa is improved by completion of a renutrition program. Dig Dis Sci. 1988 Aug;33(8):919–925. doi: 10.1007/BF01535985. [DOI] [PubMed] [Google Scholar]
  28. Russell G. F., Checkley S. A., Feldman J., Eisler I. A controlled trial of d-fenfluramine in bulimia nervosa. Clin Neuropharmacol. 1988;11 (Suppl 1):S146–S159. [PubMed] [Google Scholar]
  29. Russell G. F., Szmukler G. I., Dare C., Eisler I. An evaluation of family therapy in anorexia nervosa and bulimia nervosa. Arch Gen Psychiatry. 1987 Dec;44(12):1047–1056. doi: 10.1001/archpsyc.1987.01800240021004. [DOI] [PubMed] [Google Scholar]
  30. Sabine E. J., Yonace A., Farrington A. J., Barratt K. H., Wakeling A. Bulimia nervosa: a placebo controlled double-blind therapeutic trial of mianserin. Br J Clin Pharmacol. 1983;15 (Suppl 2):195S–202S. doi: 10.1111/j.1365-2125.1983.tb05866.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Stacher G., Bergmann H., Wiesnagrotzki S., Kiss A., Schneider C., Mittelbach G., Gaupmann G., Höbart J. Intravenous cisapride accelerates delayed gastric emptying and increases antral contraction amplitude in patients with primary anorexia nervosa. Gastroenterology. 1987 Apr;92(4):1000–1006. doi: 10.1016/0016-5085(87)90976-0. [DOI] [PubMed] [Google Scholar]
  32. Szmukler G. I. The epidemiology of anorexia nervosa and bulimia. J Psychiatr Res. 1985;19(2-3):143–153. doi: 10.1016/0022-3956(85)90010-x. [DOI] [PubMed] [Google Scholar]
  33. Toner B. B., Garfinkel P. E., Garner D. M. Long-term follow-up of anorexia nervosa. Psychosom Med. 1986 Sep-Oct;48(7):520–529. doi: 10.1097/00006842-198609000-00007. [DOI] [PubMed] [Google Scholar]
  34. Vandereycken W. Neuroleptics in the short-term treatment of anorexia nervosa. A double-blind placebo-controlled study with sulpiride. Br J Psychiatry. 1984 Mar;144:288–292. doi: 10.1192/bjp.144.3.288. [DOI] [PubMed] [Google Scholar]
  35. Vandereycken W., Pierloot R. Pimozide combined with behavior therapy in the short-term treatment of anorexia nervosa. A double-blind placebo-controlled cross-over study. Acta Psychiatr Scand. 1982 Dec;66(6):445–450. doi: 10.1111/j.1600-0447.1982.tb04501.x. [DOI] [PubMed] [Google Scholar]
  36. Walsh B. T., Stewart J. W., Roose S. P., Gladis M., Glassman A. H. Treatment of bulimia with phenelzine. A double-blind, placebo-controlled study. Arch Gen Psychiatry. 1984 Nov;41(11):1105–1109. doi: 10.1001/archpsyc.1983.01790220095015. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES